Vitrolife AB (publ)
VTRLY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $28 | $18 | $27 | $61 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $29 | $19 | $29 | $63 |
| Revenue | $4 | $4 | $3 | $2 |
| % Growth | 2.8% | 8.6% | 92.4% | – |
| Gross Profit | $2 | $2 | $2 | $1 |
| % Margin | 59.3% | 56.3% | 55% | 62.2% |
| EBITDA | $1 | -$3 | $1 | $1 |
| % Margin | 32.1% | -90.9% | 30.2% | 34.4% |
| Net Income | $1 | -$4 | $0 | $0 |
| % Margin | 14.2% | -109.7% | 12.2% | 20.3% |
| EPS Diluted | 3.78 | -28.44 | 2.91 | 2.97 |
| % Growth | 113.3% | -1,077.3% | -2% | – |
| Operating Cash Flow | $1 | $1 | $1 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $1 | $1 | $0 |